☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
HLX11
Henlius Reports First Patient Dosing with HLX11 (biosimilar- pertuzumab) for HER2-Positive Metastatic Breast Cancer and Early Brea...
September 20, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.